
Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents
Author(s) -
Mariken Dinnissen,
Andrea Dietrich,
Judith H. van der Molen,
Anne M. Verhallen,
Ynske Buiteveld,
Suzanne Jongejan,
Pieter W. Troost,
Jan K. Buitelaar,
Barbara J. van den Hoofdakker,
Pieter J. Hoekstra
Publication year - 2020
Publication title -
journal of clinical psychopharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.786
H-Index - 121
eISSN - 1533-712X
pISSN - 0271-0749
DOI - 10.1097/jcp.0000000000001322
Subject(s) - medicine , guideline , antipsychotic , adverse effect , discontinuation , pediatrics , psychiatry , schizophrenia (object oriented programming) , psychosis , quetiapine , pathology
Antipsychotics are frequently prescribed to children and adolescents for nonpsychotic indications. Guidelines recommend regularly assessing treatment response and adverse effects and the ongoing need for their use. We aimed to assess adherence to recommendations of available guidelines regarding monitoring antipsychotic use and to test the influence of children's age, sex, intelligence quotient, and diagnosis on adherence.